Comments
Threshold Pharma cancer trial result spooks investors
18.09.2012. | (Reuters) - An experimental pancreatic cancer treatment from Threshold Pharmaceuticals Inc failed to show statistically significant improvement in overall survival, spooking investors and sending its shares down as much as a third....
